| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.499 | 19.507 | 14.795 | 10.767 | 12.046 | 5.794 | 7.836 | 4.567 | 4.306 | 3.884 |
| Total Income - EUR | 13.499 | 19.507 | 14.797 | 11.597 | 12.046 | 5.794 | 7.836 | 4.567 | 4.306 | 3.884 |
| Total Expenses - EUR | 13.149 | 17.220 | 13.417 | 10.877 | 11.092 | 5.477 | 6.511 | 4.988 | 4.987 | 5.161 |
| Gross Profit/Loss - EUR | 350 | 2.287 | 1.380 | 720 | 954 | 317 | 1.325 | -421 | -681 | -1.277 |
| Net Profit/Loss - EUR | -55 | 1.897 | 1.041 | 533 | 751 | 221 | 1.221 | -558 | -681 | -1.277 |
| Employees | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Thalassa Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.237 | 0 | 0 | 56 | 36 | 1.094 | 700 | 376 | 51 | 21 |
| Current Assets | 8.903 | 8.837 | 8.685 | 8.375 | 6.849 | 6.340 | 5.665 | 5.541 | 5.105 | 4.109 |
| Inventories | 8.885 | 8.785 | 8.547 | 8.356 | 6.827 | 6.325 | 5.418 | 5.331 | 4.889 | 3.946 |
| Receivables | 0 | 0 | 0 | 0 | 5 | 2 | 0 | 0 | 0 | 0 |
| Cash | 17 | 52 | 137 | 19 | 16 | 13 | 247 | 209 | 216 | 162 |
| Shareholders Funds | 967 | 2.854 | 3.847 | 4.309 | 4.977 | 5.103 | 6.211 | 5.673 | 4.975 | 3.670 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.173 | 5.983 | 4.838 | 4.121 | 1.907 | 2.331 | 154 | 244 | 181 | 460 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Thalassa Med Srl